Molecular Partners AG
MOLN4.700USD
+0.090+1.95%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
175.78MMarket Cap
LossP/E TTM
More Details of Molecular Partners AG Company
Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
Molecular Partners AG Info
Ticker SymbolMOLN
Company nameMolecular Partners AG
IPO dateOct 22, 2014
CEOAmstutz (Patrick)
Number of employees159
Security typeDepository Receipt
Fiscal year-endOct 22
AddressWagistrasse 14
CitySCHLIEREN
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountrySwitzerland
Postal code8952
Phone41447557700
Websitehttps://www.molecularpartners.com/
Ticker SymbolMOLN
IPO dateOct 22, 2014
CEOAmstutz (Patrick)
Company Executives of Molecular Partners AG
Name
Name/Position
Position
Shareholding
Change
Dr. Michael Tobias Stumpp, Ph.D.
Dr. Michael Tobias Stumpp, Ph.D.
Executive Vice President - Projects, Member of the Management Board
Executive Vice President - Projects, Member of the Management Board
--
--
Dr. Patrick Amstutz, Ph.D.
Dr. Patrick Amstutz, Ph.D.
Chief Executive Officer, Executive Director, Member of the Management Board
Chief Executive Officer, Executive Director, Member of the Management Board
--
--
Mr. Steven H. (Steve) Holtzman, Ph.D.
Mr. Steven H. (Steve) Holtzman, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. William M. (Bill) Burns
Mr. William M. (Bill) Burns
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Seth D. Lewis
Mr. Seth D. Lewis
Senior Vice President - Investor Relations and Strategy
Senior Vice President - Investor Relations and Strategy
--
--
Mr. Sandip S. Kapadia, CPA
Mr. Sandip S. Kapadia, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Vito J. Palombella, Ph.D.
Dr. Vito J. Palombella, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Michael Vasconcelles, M.D.
Dr. Michael Vasconcelles, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Agnete B. Fredriksen, Ph.D.
Dr. Agnete B. Fredriksen, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Dominik Hoechli, M.D.
Dr. Dominik Hoechli, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Michael Tobias Stumpp, Ph.D.
Dr. Michael Tobias Stumpp, Ph.D.
Executive Vice President - Projects, Member of the Management Board
Executive Vice President - Projects, Member of the Management Board
--
--
Dr. Patrick Amstutz, Ph.D.
Dr. Patrick Amstutz, Ph.D.
Chief Executive Officer, Executive Director, Member of the Management Board
Chief Executive Officer, Executive Director, Member of the Management Board
--
--
Mr. Steven H. (Steve) Holtzman, Ph.D.
Mr. Steven H. (Steve) Holtzman, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. William M. (Bill) Burns
Mr. William M. (Bill) Burns
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Seth D. Lewis
Mr. Seth D. Lewis
Senior Vice President - Investor Relations and Strategy
Senior Vice President - Investor Relations and Strategy
--
--
Mr. Sandip S. Kapadia, CPA
Mr. Sandip S. Kapadia, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
Switzerland
0.00
0.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sun, Aug 17
Updated: Sun, Aug 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Suvretta Capital Management, LLC
5.94%
BVF Partners L.P.
3.62%
Other
90.44%
Shareholders
Shareholders
Proportion
Suvretta Capital Management, LLC
5.94%
BVF Partners L.P.
3.62%
Other
90.44%
Shareholder Types
Shareholders
Proportion
Hedge Fund
9.56%
Other
90.44%
Institutional Shareholding
Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
15
3.58M
9.57%
-32.28K
2025Q3
15
3.59M
9.59%
-23.51K
2025Q2
16
3.58M
9.72%
-44.38K
2025Q1
16
3.58M
9.72%
-44.38K
2024Q4
16
3.58M
10.80%
+1.75M
2024Q3
19
850.31K
2.56%
-138.97K
2024Q2
20
861.27K
2.60%
-213.87K
2024Q1
22
946.77K
2.88%
-611.83K
2023Q4
26
957.56K
2.63%
-624.65K
2023Q3
28
961.52K
2.93%
-686.56K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Suvretta Capital Management, LLC
2.22M
5.94%
--
--
Sep 30, 2025
BVF Partners L.P.
1.35M
3.62%
--
--
Sep 30, 2025
Geode Capital Management, L.L.C.
1.07K
0%
--
--
Nov 30, 2025
Morgan Stanley & Co. LLC
367.00
0%
--
--
Sep 30, 2025
UBS Financial Services, Inc.
5.34K
0.01%
-4.86K
-47.65%
Sep 30, 2025
BofA Global Research (US)
157.00
0%
--
--
Sep 30, 2025
EverSource Wealth Advisors, LLC
155.00
0%
+114.00
+278.05%
Sep 30, 2025
Rhumbline Advisers Ltd. Partnership
--
0%
-269.00
-100.00%
Jun 30, 2025
Qube Research & Technologies Ltd
--
0%
-16.00
-100.00%
Sep 30, 2024
Old Mission Capital LLC
--
0%
-10.37K
-100.00%
Sep 30, 2024
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
